Alcon AG
SIX:ALC

Watchlist Manager
Alcon AG Logo
Alcon AG
SIX:ALC
Watchlist
Price: 77.22 CHF 0.97% Market Closed
Market Cap: 38.6B CHF
Have any thoughts about
Alcon AG?
Write Note

Alcon AG
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alcon AG
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Alcon AG
SIX:ALC
Income from Continuing Operations
$974m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Income from Continuing Operations
CHf12.3m
CAGR 3-Years
-22%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Medartis Holding AG
SIX:MED
Income from Continuing Operations
CHf4m
CAGR 3-Years
-30%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Income from Continuing Operations
CHf74.4m
CAGR 3-Years
126%
CAGR 5-Years
45%
CAGR 10-Years
15%
IVF Hartmann Holding AG
SIX:VBSN
Income from Continuing Operations
CHf17.6m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
1%
No Stocks Found

Alcon AG
Glance View

Market Cap
38.2B CHF
Industry
Health Care

Alcon AG, headquartered in Geneva, Switzerland, emerges as a global leader in eye care, having spun off from Novartis in 2019 to operate independently. The company traces its roots back to a small pharmacy established in Fort Worth, Texas, in 1945, gradually expanding under the strategic vision of its founders. Today, Alcon stands at the intersection of innovation and necessity, catering to a world increasingly aware of eye health. The firm specializes in two main sectors: Surgical and Vision Care. In the Surgical division, Alcon offers advanced technologies and devices for ophthalmic surgery, encompassing cataract, retinal, and refractive procedures. Through these innovations, Alcon not only enhances patient outcomes but also streamlines operations for eye care professionals, carving out a significant market share in surgical solutions. Meanwhile, the Vision Care segment thrives by addressing the burgeoning demand for contact lenses and ocular health products. Alcon’s portfolio features daily disposable and reusable lenses, supported by innovative technologies that prioritize comfort and clarity of vision. Additionally, the company provides comprehensive eye care products, including lens care solutions, which enhance user satisfaction and ensure sustained demand. Alcon’s revenue model hinges on its ability to deliver cutting-edge products that meet the evolving needs of consumers and professionals alike. Through strategic investments in research and development and a strong distribution network, Alcon perpetually reinforces its market presence, securing its position as a formidable player in the eye care industry.

ALC Intrinsic Value
70.41 CHF
Overvaluation 9%
Intrinsic Value
Price

See Also

What is Alcon AG's Income from Continuing Operations?
Income from Continuing Operations
974m USD

Based on the financial report for Dec 31, 2023, Alcon AG's Income from Continuing Operations amounts to 974m USD.

What is Alcon AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
191%

Over the last year, the Income from Continuing Operations growth was 191%.

Back to Top